FDA Approves First of New Migraine Drugs

650x350_new_cgrp_treatment_targets_migraines_video

The FDA has approved the first in a new class of migraine drugs, called CGRP inhibitors, that aim to head off fight painful migraine headaches before they start.

This post was syndicated from WebMD Health. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply